Saffron Benefits & Research: What Studies Actually Say
Saffron Benefits & Research
A scholarly look at what studies have explored about saffron — from mood and cognition to antioxidant activity, traditional use, and culinary rituals.
Evidence matters. Claims should be careful. Saffron is powerful in color, aroma, and tradition — but health research must be presented honestly.
Where the research has focused
Eight areas where saffron has drawn the most peer-reviewed attention. Each card links to a detailed section with citations, limitations, and honest framing.
Mood & Emotional Wellbeing
Several randomized trials and meta-analyses have explored saffron extracts and self-reported mood outcomes. Results are encouraging but evidence quality varies.
Read section →Sleep & Relaxation
A small number of randomized trials have looked at saffron extracts and self-reported sleep quality. More replication is needed before strong claims.
Read section →Cognitive Function & Memory
Trials in mild-to-moderate Alzheimer's disease and mild cognitive impairment have explored saffron extracts as adjuncts. Effects are modest and study sizes small.
Read section →Eye Health Research
Small studies in early age-related macular degeneration have explored saffron supplementation and retinal flicker sensitivity. Promising but preliminary.
Read section →Antioxidants & Inflammation
In vitro and animal research has characterized free-radical-scavenging activity of saffron compounds. Human evidence is more limited.
Read section →Women's Health / PMS
A double-blind randomized trial has explored saffron's effect on premenstrual symptoms in women with regular cycles. Pregnancy caution still applies.
Read section →Metabolic Markers
Meta-analyses of small trials have explored saffron supplementation and markers such as fasting glucose, lipids, and blood pressure. Results are mixed.
Read section →Traditional Culinary Practice
Centuries of culinary and cultural use — Afghan, Persian, Indian, Mediterranean. Tradition is meaningful, but it is not the same as clinical proof.
Read section →Evidence grading
A simple key we use throughout this page. Not every study carries equal weight, and we believe a careful brand should say so out loud.
Multiple high-quality human clinical trials, or systematic reviews / meta-analyses pooling several such trials.
Some human studies with consistent direction, but more research is needed before drawing firm conclusions.
Early human evidence, small trials, or mixed results across studies.
Animal, cell, or lab studies only — biologically interesting, but does not establish a clinical effect in humans.
Longstanding culinary or cultural practice. Meaningful as heritage, but distinct from clinical proof.
Saffron & Mood Research
Saffron is one of the most-studied culinary spices in the context of self-reported mood. A 2019 systematic review and meta-analysis published in Nutrition Reviews pooled 23 randomized controlled trials and reported large effect sizes for saffron versus placebo on depressive and anxiety symptoms, while also flagging evidence of publication bias and a lack of regional diversity in the underlying trials.[1] An earlier 2013 meta-analysis in the Journal of Integrative Medicine aggregated five randomized trials in adults with major depressive disorder and found saffron supplementation outperformed placebo while not significantly differing from standard antidepressants — a finding the authors described as preliminary given the small number of pooled trials.[2] A 2019 meta-analysis in Planta Medica reached a similar direction for mild-to-moderate depression specifically.[3]
What the evidence suggests: studies using standardized saffron extracts have observed reductions in self-rated mood symptoms compared with placebo in adults with mild-to-moderate symptoms.
Related: Our journal piece on saffron and mood · Culinary saffron vs. clinical extract
Saffron & Sleep / Relaxation Research
A 28-day randomized, double-blind, placebo-controlled trial published in the Journal of Clinical Sleep Medicine in 2020 examined a standardized saffron extract (14 mg twice daily) in 63 healthy adults with self-reported poor sleep. The supplemented group reported improvements on the Insomnia Severity Index and Restorative Sleep Questionnaire compared with placebo.[4] A 2023 systematic review of randomized trials on saffron and sleep quality concluded that early evidence is encouraging but inconsistent, with trials varying by extract type, dose, and population.[5]
What the evidence suggests: some adults with self-reported sleep complaints have reported improved subjective sleep measures while taking standardized saffron extracts in short trials.
Related: Our piece on saffron and evening tea traditions · Saffron tea recipe
Saffron & Cognition / Memory Research
Two early randomized trials by Akhondzadeh and colleagues are frequently cited in this literature. A 16-week, placebo-controlled study in 46 patients with probable mild-to-moderate Alzheimer's disease, published in the Journal of Clinical Pharmacy and Therapeutics in 2010, reported greater improvement on cognitive assessment scores in the saffron group.[6] A 22-week multicenter trial published in Psychopharmacology compared saffron at 30 mg/day with the cholinesterase inhibitor donepezil and reported similar cognitive outcomes between groups, with fewer vomiting events in the saffron arm.[7] A 2020 systematic review and meta-analysis in BMC Complementary Medicine and Therapies pooled four trials in mild cognitive impairment and Alzheimer's and concluded that saffron may improve cognitive function on standardized scales relative to placebo, while noting the evidence base is small and not yet sufficient for clinical recommendations.[8]
What the evidence suggests: in a small body of randomized trials, standardized saffron extracts have shown effects on cognitive assessment scales in patients with mild cognitive impairment or mild-to-moderate Alzheimer's disease.
Related: Learn About Saffron · Study table
Saffron & Eye Health Research
A 90-day crossover trial published in Investigative Ophthalmology & Visual Science in 2010 examined 20 mg/day of saffron in 25 patients with early age-related macular degeneration (AMD) and reported improvements in retinal flicker sensitivity on focal electroretinography relative to placebo.[9] A longitudinal follow-up published in Evidence-Based Complementary and Alternative Medicine in 2012 reported the early gains were sustained over additional months of supplementation in the same cohort.[10] Subsequent small randomized trials in AMD have continued to explore this signal, but study sizes remain modest.
What the evidence suggests: small studies in early AMD have observed short-term changes in measures of retinal function with daily saffron supplementation.
Saffron, Antioxidants & Inflammation Markers
Much of the antioxidant literature on saffron is based on cell and animal models. Reviews of saffron's apocarotenoids — crocin, crocetin, safranal, and picrocrocin — describe free-radical-scavenging activity in vitro and modulation of oxidative stress markers in animal models.[11] A 2021 systematic review and meta-analysis of randomized human trials reported that saffron supplementation was associated with changes in select oxidative stress biomarkers (such as malondialdehyde and total antioxidant capacity), while noting heterogeneity across trials.[12]
What the evidence suggests: saffron compounds show antioxidant activity in laboratory settings, and a smaller human literature has measured changes in some oxidative stress biomarkers.
Related: Compound explainer
Saffron & Women's Health / PMS Research
A 2008 double-blind, randomized, placebo-controlled trial in BJOG: An International Journal of Obstetrics & Gynaecology examined 30 mg/day of saffron over two menstrual cycles in 50 women aged 20–45 with a history of premenstrual syndrome (PMS). Compared with placebo, the saffron group reported greater reductions in total daily premenstrual symptom scores and on the Hamilton Depression Rating Scale.[13] The findings have been examined in subsequent reviews of herbal options for PMS, which generally note the trial is small and warrants replication.
What the evidence suggests: a small randomized trial reported reductions in self-rated premenstrual symptoms with saffron supplementation over two cycles, compared with placebo.
Saffron & Metabolic Health Research
A 2019 systematic review and meta-analysis in Complementary Therapies in Medicine pooled randomized trials of saffron supplementation and reported changes in fasting blood glucose and certain lipid markers compared to control, while noting modest effect sizes and heterogeneity between trials.[14] A separate dose-response meta-analysis in 2023 examining saffron and cardiovascular risk factors reported small effects on diastolic blood pressure and body composition, again with substantial heterogeneity across studies.[15]
What the evidence suggests: across small randomized trials, saffron supplementation has been associated with modest changes in selected metabolic markers, with high variability between studies.
Saffron in Traditional Culinary Practice
For centuries, saffron has been central to Afghan, Persian, Indian, Mediterranean, and Central Asian cooking — coloring rice (kabuli pulao, chelow, tahdig, biryani), perfuming desserts (sheer yakh, sholeh zard, firni), enriching tea (qahwa, chai-e zaferani), and marking weddings, religious holidays, and acts of hospitality. Cultural practice is meaningful and worth preserving on its own terms.
What this means: a long tradition of culinary use tells us about flavor, color, ritual, and the role of saffron in food culture. It does not equal a clinical trial. Both kinds of knowledge can be respected without conflating them.
Related: Afghan saffron heritage · Recipe library · Sourcing & provenance
Study table
Selected, peer-reviewed studies referenced on this page. Where details aren't available in the public abstract, we say so rather than guess.
| Topic | Study (authors, year) | Type | Population | Saffron form / dose | Main finding | Limitation | Link |
|---|---|---|---|---|---|---|---|
| Mood & anxiety | Marx et al., 2019 | Systematic review & meta-analysis (23 RCTs) | Adults; mixed mood/anxiety populations | Standardized saffron extracts; doses vary | Saffron showed a large positive effect size vs. placebo for depressive and anxiety symptoms. | Evidence of publication bias; limited regional diversity in trials. | PMID 31135916 |
| Mood (MDD) | Hausenblas et al., 2013 | Meta-analysis (5 RCTs) | Adults with major depressive disorder | Saffron supplements; doses vary by trial | Significant effect vs. placebo; not significantly different from standard antidepressants. | Small number of pooled trials; not specified in abstract for every parameter. | PMID 24299602 |
| Sleep | Lopresti et al., 2020 | 28-day RCT, double-blind, placebo-controlled | 63 healthy adults; self-reported poor sleep | Saffron extract (affron), 14 mg twice daily | Improvements on Insomnia Severity Index and Restorative Sleep Questionnaire vs. placebo. | Single trial; short duration; self-report measures. | PMID 32056539 |
| Cognition (AD) | Akhondzadeh et al., 2010 (16-week) | RCT, double-blind, placebo-controlled | 46 patients; probable mild-to-moderate Alzheimer's disease | Saffron capsules, 30 mg/day | Greater improvement on cognitive assessment scores vs. placebo over 16 weeks. | Single-center, small sample, short follow-up. | PMID 20831681 |
| Cognition (AD) | Akhondzadeh et al., 2010 (22-week) | Multicenter RCT vs. donepezil | Patients with mild-to-moderate Alzheimer's disease | Saffron 30 mg/day vs. donepezil | Cognitive outcomes similar between groups; fewer vomiting events in saffron arm. | Iran-based trial; replication outside region limited. | PMID 19838862 |
| Cognition (MCI/dementia) | Ayati et al., 2020 | Systematic review & meta-analysis (4 RCTs) | Adults with MCI or mild-moderate Alzheimer's | Saffron, mostly 30 mg/day | Improved scores on ADAS-cog and CDR-SB vs. placebo; no significant difference vs. conventional medication. | Authors note evidence base too small for clinical recommendations. | PMID 33167948 |
| Eye health (early AMD) | Falsini et al., 2010 | Crossover RCT, 90 days | 25 patients with early AMD | Saffron, 20 mg/day | Improved retinal flicker sensitivity on focal electroretinography vs. baseline/placebo. | Very small sample; short-term outcomes. | PMID 20688744 |
| PMS | Agha-Hosseini et al., 2008 | RCT, double-blind, placebo-controlled, 2 cycles | 50 women, ages 20–45, regular cycles, history of PMS | Saffron capsules, 30 mg/day (15 mg twice daily) | Greater reduction in total premenstrual daily symptom scores and HDRS vs. placebo by cycles 3–4. | Single-center; small sample; short follow-up. | PMID 18271889 |
| Metabolic | Pourmasoumi et al., 2019 | Systematic review & meta-analysis | Adults; pooled RCTs | Not specified consistently across trials | Some changes in fasting blood glucose and lipid markers vs. control; heterogeneity high. | Modest effect sizes; trial heterogeneity. | PMID 31779990 |
What makes saffron interesting to researchers?
Saffron's distinctive color, aroma, and bitter taste come from a small family of apocarotenoids — the same compounds that draw scientific attention.[11] Researching these compounds in the lab is not the same as showing that culinary saffron produces a medical effect in people.
Crocin
A water-soluble carotenoid glycoside responsible for saffron's deep yellow-orange hue when bloomed. Studied for free-radical-scavenging activity in lab settings.
Crocetin
The carotenoid acid backbone of crocin. Investigated in preclinical models for various biological activities; clinical relevance still under study.
Safranal
A volatile aromatic compound responsible for saffron's distinctive scent. Forms during drying as picrocrocin is enzymatically converted.
Picrocrocin
A bitter glycoside that gives saffron its characteristic taste. Cleaves on drying to generate safranal — which is why properly dried saffron is more fragrant.
Culinary saffron is not the same as a clinical extract.
Most studies discussed on this page use standardized saffron extracts at fixed daily doses — typically 28–30 mg of a specific extract, encapsulated and quality-controlled for research. A pinch of saffron in your rice or tea is something else entirely: a culinary ingredient, with all the variability of food. Raihan Saffron is sold for cooking, blooming, brewing, and gifting — for color, aroma, and ritual. Not as a clinical supplement, and not as a substitute for medical care.
Careful answers to common questions
We err on the side of caution. If you're trying to make a health decision, please bring these questions to your clinician.
Is saffron healthy?
Saffron is a culinary spice. Researchers have studied compounds in saffron for various biological activities, and some randomized trials have explored standardized extracts in adults. None of that is the same as a clinical claim that culinary saffron will produce a specific health outcome for you. The most honest answer is: saffron is a flavorful spice with interesting compounds, used in moderation as part of food.
Can saffron treat depression or anxiety?
No. We don't claim saffron treats any condition. Several randomized trials and meta-analyses have explored saffron extracts and self-rated mood, with promising signals — but trials are small, use standardized extracts (not culinary saffron), and the field's authors themselves call for more replication. If you're navigating depression or anxiety, please work with a qualified healthcare professional.
Is saffron safe?
Culinary amounts of saffron — a pinch in rice, tea, or dessert — have a long history of food use across many cuisines. Higher supplemental amounts may not be appropriate for everyone. People who are pregnant, breastfeeding, taking medications, or managing a medical condition should consult a healthcare professional before using saffron at supplemental doses.
How much saffron should I use in cooking?
For most recipes, a small pinch — roughly 10–20 threads — is enough. Bloom the threads in 2–3 tablespoons of warm (not boiling) water, milk, stock, or wine for at least 10–15 minutes. Add the liquid and the threads to your dish so you capture both color and aroma. See our how-to-use-saffron guide for details.
Is Raihan Saffron a supplement?
No. Raihan Saffron is sold as a culinary spice — all-red Afghan Super Negin threads, hand-packed in Lynn, Massachusetts. It is not formulated, dosed, or marketed as a dietary supplement, medical product, or treatment for any condition.
Continue from here
The most useful next step depends on what you're here for.
Start with real saffron — for color, aroma, and ritual.
Research may explore saffron's compounds, but the first experience is simple: a few threads blooming into gold, the room turning faintly floral, the rice taking on a slow amber glow.
References
Peer-reviewed sources cited above. All links point to PubMed or the publishing journal.
- Marx W, Lane M, Rocks T, et al. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutrition Reviews. 2019;77(8):557–571. PubMed 31135916 · doi:10.1093/nutrit/nuz023
- Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine. 2013;11(6):377–383. PubMed 24299602 · doi:10.3736/jintegrmed2013056
- Tóth B, Hegyi P, Lantos T, et al. The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis. Planta Medica. 2019;85(1):24–31. PubMed 30036891 · doi:10.1055/a-0660-9565
- Lopresti AL, Smith SJ, Metse AP, Drummond PD. Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Sleep Medicine. 2020;16(6):937–947. PubMed 32056539 · doi:10.5664/jcsm.8376
- Cerdá-Bernad D, Costa L, Serra AT, et al. Saffron and sleep quality: a systematic review of randomized controlled trials. Nutrients. 2023. PubMed 37484523
- Akhondzadeh S, Sabet MS, Harirchian MH, et al. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics. 2010;35(5):581–588. PubMed 20831681
- Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology. 2010;207(4):637–643. PubMed 19838862
- Ayati Z, Yang G, Ayati MH, Emami SA, Chang D. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complementary Medicine and Therapies. 2020;20:333. PubMed 33167948 · doi:10.1186/s12906-020-03102-3
- Falsini B, Piccardi M, Minnella A, et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Investigative Ophthalmology & Visual Science. 2010;51(12):6118–6124. PubMed 20688744
- Piccardi M, Marangoni D, Minnella AM, et al. A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function. Evidence-Based Complementary and Alternative Medicine. 2012;2012:429124. PubMed 22852021
- Christodoulou E, Kadoglou NP, Kostomitsopoulos N, Valsami G. Saffron: a natural product with potential pharmaceutical applications. Reviews of saffron apocarotenoids — crocin, crocetin, safranal, picrocrocin — covering chemistry and bioactivity. Phytotherapy Research and related journals. See also: Bukhari SI et al., overview review (2018). PubMed 30136324
- Asbaghi O, et al. Effect of saffron supplementation on oxidative stress parameters: a systematic review and meta-analysis of randomized placebo-controlled trials. Food Science & Nutrition. 2021. PMC8498059
- Agha-Hosseini M, Kashani L, Aleyaseen A, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG. 2008;115(4):515–519. PubMed 18271889 · doi:10.1111/j.1471-0528.2007.01652.x
- Pourmasoumi M, Hadi A, Najafgholizadeh A, et al. The effect of saffron supplementation on blood glucose and lipid profile: a systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 2019;47:102158. PubMed 31779990
- Setayesh L, Ashtary-Larky D, Clark CCT, et al. The effects of saffron supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis. Frontiers in Nutrition. 2022. PubMed 36570145